Descartes-08

About This Treatment

Myeloma Clinical Trials


Recently Updated

Study of CD8+ anti-BCMA CAR T-cells in Patients with Multiple Myeloma

This Phase 1 study will evaluate the safety and feasibility of an investigational CAR-T cell therapy called Descartes-08 in eligible patients with active multiple myeloma.

Learn more about this trial

Treatment Information
Developed By

Cartesian Therapeutics

Treatment Classifications

Create Your Account

Create your account today and get matched to myeloma treatments and trials around the US.

  • Find treatments with eligible clinical trials.
  • Get a second opinion from a myeloma specialist.
  • Receive alerts when new treatments become available.
  • Our services are always free for patients and HIPAA compliant.

Create Account


Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;